Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report

Nejadrahim, Rahim; Khademolhosseini, Sara; Kavandi, Hadiseh; Hajizadeh, Reza

doi:10.1186/s13256-021-02751-3

Cited by 8 publications

(3 citation statements)

References 16 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, Bhattacharyya et al reported a case of Takotsubo cardiomyopathy at the 38th week of pregnancy [ 56 ]. In a case of a young pregnant woman reported by Nejadrahim et al, cardiomiopathy with a left ventricular ejection fraction of 40% was observed [ 57 ]. Soofi et al reported acute heart failure and venous thrombosis in a case of a 25-year-old pregnant women infected with SARS-CoV-2.…”

Section: Resultsmentioning

confidence: 99%

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Yaghoobpoor

Fathi

Vakili

et al. 2022

JCM

View full text Add to dashboard Cite

Background: COVID-19 is a viral infectious disease leading to a spectrum of clinical complications, especially cardiovascular. Evidence shows that this infection can potentially accompany a worse outcome in pregnant women. Cardiovascular complications in mothers and their fetuses are reported by previous studies. Objective: In this systematic review, we aim to investigate the cardiovascular complications of COVID-19 during pregnancy in the mothers and fetus, according to the published literature. Method: We systematically searched the online databases of PubMed, Scopus, Web of Science, and Google Scholar, using relevant keywords up to April 2022. We included all observational studies reporting cardiovascular complications among COVID-19-affected pregnant women and their fetuses. Results: We included 74 studies containing 47582 pregnant COVID-19 cases. Pre-eclampsia, hypertensive disorders, cardiomyopathy, heart failure, myocardial infarction, thrombosis formation, alterations in maternal–fetal Doppler patterns, and maternal and fetal arrhythmia were reported as cardiovascular complications. The highest incidences of pre-eclampsia/eclampsia among COVID-19 pregnant cases, reported by studies, were 69% and 62%, and the lowest were 0.5% and 3%. The highest and lowest incidences of fetal bradycardia were 20% and 3%, and regarding fetal tachycardia, 5.4% and 1%, respectively. Conclusion: SARS-CoV-2 infection during pregnancy can potentially be associated with cardiovascular complications in the mother, particularly pre-eclampsia and heart failure. Moreover, SARS-CoV-2 infection during pregnancy can potentially cause cardiovascular complications in the fetus, particularly arrhythmia.

show abstract

Section: Resultsmentioning

confidence: 99%

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Yaghoobpoor

Fathi

Vakili

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…In one series of 113 deceased patients, CHF occurred in one quarter of non-pregnant COVID-19 patients [ 49 ]. Cardiomyopathies among pregnant COVID-19 patients may be due to a peripartum [ 50 , 51 ], sepsis or stress mediated (Takotsubo) cardiomyopathy [ 52 ]. Peripartum cardiomyopathy (PPCM) is a diagnosis of exclusion and differentiating between PPCM and COVID-19 mediated cardiomyopathy may prove to be clinically challenging.…”

Section: Covid-19 and Cardiac Involvement In Pregnancymentioning

confidence: 99%

A Review of Cardiovascular Complications among Pregnant Patients with COVID-19

Pruzansky¹,

Slade²,

Stephenson³

et al. 2022

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Cardiovascular complications of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection are well-described in the general population but remain limited among pregnant patients. This review summarizes data from case reports, case series, and observational studies of cardiovascular manifestations of corona virus disease 2019 (COVID-19) in pregnant patients and provides recommendations to the cardiovascular clinician regarding management considerations in this vulnerable population. Pregna is an immunocompromised state in which cardiovascular demands are increased. Cardiovascular complications of COVID-19 that have been described in pregnancy include myocardial injury, cardiomyopathy, thromboembolism, pre-eclampsia and arrhythmia. Physiologic and cardiovascular changes in pregnancy predispose pregnant patients with COVID-19 to more severe illness than the general population. Black or Hispanic race, obesity, diabetes, hypertension and lung disease are risk factors for more severe infection, maternal death and adverse perinatal outcomes. Pregnant patients with severe COVID-19 disease compared with non-pregnant age-matched women with COVID infection are more likely to be admitted to the intensive care unit (ICU), receive mechanical ventilation and require advanced mechanical circulatory support. Cardiovascular complications of COVID-19 in pregnant patients requires further attention, particularly given the anticipated increase in birth volume and ongoing nature of COVID-19 pandemic with novel variants. Clinicians should have a lower threshold for cardiac testing and multidisciplinary management in pregnant women with severe COVID-19 disease. Given the persistence of COVID-19 within our communities, diagnostic laboratory and imaging testing for high-risk pregnant patients hospitalized with COVID-19 infection should be routine. We strongly urge the implementation of a cardio-obstetric multidisciplinary team in individually managing these high-risk patients in an effort to improve maternal and fetal outcomes.

show abstract

“…Differentiating between postpartum cardiomyopathy and COVID-19-related cardiomyopathy in infected pregnant women is challenging. The case of a young pregnant woman who exhibited signs of heart failure with pulmonary edema following cesarean section has been presented in the literature [ 57 ]. Coagulopathy is considered to be associated with COVID-19, which in turn may result in the onset of further complications, including deep vein thrombosis [ 58 ].…”

Section: Complications Of Covid-19 Reported In Pregnancymentioning

confidence: 99%

The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?

Kalampokas

Rapani

Παπαγεωργίου

et al. 2021

Viruses

View full text Add to dashboard Cite

Despite the volume of publications dedicated to unraveling the biological characteristics and clinical manifestations of SARS-CoV-2, available data on pregnant patients are limited. In the current review of literature, we present an overview on the developmental course, complications, and adverse effects of COVID-19 on pregnancy. A comprehensive review of the literature was performed in PubMed/Medline, Embase, and Cochrane Central databases up to June 2021. This article collectively presents what has been so far reported on the identified critical aspects, namely complications during pregnancy, delivery challenges, neonatal health care, potential routes of viral transmission, including vertical transmission or breastfeeding, along with the risks involved in the vaccination strategy during pregnancy. Despite the fact that we are still largely navigating uncharted territory, the observed publication explosion in the field is unprecedented. The overwhelming need for data is undoubtable, and this serves as the driver for the plethora of publications witnessed. Nonetheless, the quality of data sourced is variable. In the midst of the frenzy for reporting on SARS-CoV-2 data, monitoring this informational overload is where we should head to next, considering that poor quality research may in fact hamper our attempts to prevail against this unparalleled pandemic outbreak.

show abstract

Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report

Cited by 8 publications

References 16 publications

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

A Review of Cardiovascular Complications among Pregnant Patients with COVID-19

The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?

Contact Info

Product

Resources

About